FDA Adds $24.2 Million To Unapproved Drug Initiative Scorecard
This article was originally published in The Tan Sheet
Executive Summary
Two weeks after FDA officials attempted to explain how well the Center for Drug Evaluation and Research's unapproved drug initiative is working, the agency showed how actions often speak louder than words